Trial intelligence / Profile preview

Propofol vs Ketamine-Dexmedetomidine for MEP in Pediatric Tethered Cord Surgery

NCT05591001Phase 1Completed

Sponsor
Cairo University
Start
Oct 2022
Primary completion
Mar 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of ketamine and dexmedetomidine in Tethered cord syndrome (TCS) (2 arms), sponsored by Cairo University. Primary endpoint: Mean microvolts of Motor Evoked Potentials at 2 hours. Started Oct 2022; status: completed.

02

Drugs

ketaminedexmedetomidine
03

Conditions

Tethered cord syndrome (TCS)

Beyond the preview

Go deeper on NCT05591001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05591001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call